ACADIA Pharmaceuticals (ACAD)

ACADIA Pharmaceuticals (ACAD) Financial Statements


ACADIA Pharmaceuticals Financial Overview

ACADIA Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.337; its P/E ratio is -13.84; ACADIA Pharmaceuticals is scheduled to report earnings on May 3, 2023, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 136.49M$ 130.71M$ 134.56M$ 115.47M$ 130.76M
Gross Profit$ 134.08M$ 128.58M$ 131.90M$ 112.52M$ 128.20M
EBIT$ -46.06M$ -30.87M$ -33.65M$ -113.02M$ -44.66M
EBITDA$ -45.57M$ -30.36M$ -33.14M$ -112.50M$ -44.12M
Net Income Common Stockholders$ -41.73M$ -27.18M$ -34.01M$ -113.06M$ -43.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 416.82M$ 436.58M$ 436.35M$ 445.98M$ 520.71M
Total Assets$ 587.81M$ 602.49M$ 612.77M$ 624.25M$ 700.12M
Total Debt$ 62.00M$ 63.00M$ 63.72M$ 64.42M$ 64.43M
Net Debt$ -354.82M$ -373.58M$ -372.63M$ -381.56M$ -456.28M
Total Liabilities$ 187.40M$ 176.81M$ 177.92M$ 179.45M$ 159.23M
Stockholders Equity$ 400.41M$ 425.69M$ 434.85M$ 444.80M$ 540.89M
Cash Flow-
Free Cash Flow$ -23.85M$ -727.00K$ -13.13M$ -76.33M$ -23.12M
Operating Cash Flow$ -23.85M$ -727.00K$ -13.13M$ -76.33M$ -23.12M
Investing Cash Flow$ -17.75M$ 15.44M$ -55.80M$ 131.34M$ 71.55M
Financing Cash Flow$ 1.61M$ 287.00K$ 3.83M$ 2.47M$ 4.37M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

ACADIA Pharmaceuticals Debt to Assets

ACADIA Pharmaceuticals Cash Flow

ACADIA Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis